A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)
A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)
Active, not recruiting · NCT06128564 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Active, not recruiting | Phase 2 | 2026-09-09 | NCT06128564 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoffmann-La Roche | 280 |
| Sarepta Therapeutics, Inc. | 15 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chr de La Citadelle | Liège | Belgium | 1 |
| Great Ormond Street Hospital for Children | London | United Kingdom | 24 |
| Hospital Sant Joan De Deu | Esplugues de Llobregas | Spain | 5 |
| Hôpital Necker-Enfants Malades | Paris | France | 35 |
| John Radcliffe Hospital | Oxford | United Kingdom | 24 |
| PU A. Gemelli, Università Cattolica del Sacro Cuore | Rome | Italy | 1 |
| Universitätsklinikum Essen | Essen | Germany | 39 |